Integrating tumor localization, uptake patterns (focal vs. diffuse), and PSMA intensity (SUVmax), the PRIMARY score was established to standardize lesion interpretation and enhance the differentiation of csPCa from clinically insignificant disease [11]. The gene discussed is FOLH1; the disease is neoplasm.